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dišnog sustava - Rezultati prve godine četverogodišnjeg prospektivnog istraživanja
Abstract
Background. Human bocavirus (HBoV) is a recently discovered parvovirus that 
may cause respiratory disease. The aim of this study was to determine HBoV 
prevalence among hospitalized children with acute respiratory tract infection 
(ARI) in two Croatian hospitals, Children’s Hospital Zagreb and General Hos-
pital Karlovac, and to compare it with prevalence of other respiratory viruses.
Methods. From May 2017 to April 2018 nasopharyngeal and pharyngeal swabs 
from a total of 275 children with ARI of suspected viral etiology were obtained 
and tested by multiplex- PCR for the presence of 15 respiratory viruses, includ-
ing HBoV.
Results. Viral etiology was proved in 221/275 (80.4%) of the patients. HBoV 
was detected in 17 (6.2 %) samples. Two thirds of HBoV positive patients were 
between one and three years of age. HBoV was detected in older children when 
compared to the children infected with respiratory syncytial virus (P < 0.001), 
but younger when compared to those infected with influenza (P = 0.009). Sev-
enty six percent of HBoV positive patients had upper and 24% lower respira-
tory tract infection. HBoV was more often detected in multiple virus infec-
tions compared to the other respiratory viruses (P < 0.001). HBoV is detected 
throughout the year except for the summer months.
Conclusion. Human bocavirus, although often detected in combination with 
other respiratory viruses, is one of the possible causes of ARI in children. Con-
tinuous laboratory detection of HBoV in the respiratory secretion of children 
with ARI is required in order to complete our findings on clinical significance 
and epidemiology of this infection.
Sažetak
Uvod. Humani bokavirus (HBoV) je nedavno otkriveni parvovirus koji može 
uzrokovati bolest dišnog sustava. Cilj ove studije je odrediti prevalenciju HBoV 
u djece primljene zbog akutne respiratorne infekcije (ARI) u dvije hrvatske bol-
nice, u Kliniku za dječje bolesti Zagreb i Opću bolnicu Karlovac te usporediti s 
prevalencijom drugih respiratornih virusa.
Metode. Od svibnja 2017. do travnja 2018. testirano je ukupno 275 obrisaka 
nazofarinksa i ždrijela prikupljenih od djece s ARI sa sumnjom na virusnu eti-
ologiju. Uzorci su testirani metodom multipleks-PCR na prisutnost 15 respira-
tornih virusa uključujući i HBoV.
Rezultati. Virusna etiologija je dokazana u 221/275 (80,4%) bolesnika. HBoV 
je detektiran u 17 (6,2 %) kliničkih uzoraka. Većina djece s HBoV infekcijom 
(70,2 %) bila je u dobi između jedne i tri godine. Djeca u kojih je detektiran 
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Zaključak
Humani bokavirus, iako često detektiran u kombinaciji s drugim 
respiratornim virusima, jedan je od mogućih uzročnika ARI u 
djece. Potrebna je kontinuirana laboratorijska detekcija ovog vi-
rusa u respiratornom sekretu djece s ARI kako bismo upotpunili 
saznanja o kliničkom značenju i epidemiologiji ove infekcije.
(P < 0.001), ali mlađa od djece inficirane virusom influence (P 
= 0.009). Tri četvrtine HBoV inficirane djece imalo je dijagnozu 
infekcije gornjeg dišnog sustava (76%), dok je 24% djece imalo 
infekciju donjeg dišnog sustava. HBoV je značajno češće doka-
zan u koinfekciji s nekim od ostalih respiratornih virusa u odno-
su na druge respiratorne viruse (P < 0.001). Virus je detektiran 
tijekom cijele godine, izuzev ljetnih mjeseci.
Introduction
 Human bocavirus (HBoV) is a recently discovered 
parvovirus that can be present in the respiratory tract of 
patients with acute respiratory infection (ARI), as well as 
in the gastrointestinal tract of patients with gastroenteri-
tis, but its etiologic involvement in the underlying diseas-
es is still uncertain. The virus was discovered in 2005 in 
Sweden by Tobias Allander et al. [1], using a system of 
genomic virus screening in nasopharyngeal samples of 17 
children with acute respiratory disease. The newly iden-
tified virus shared sequence similarities and genomic or-
ganization with the bovine parvovirus and a minute virus 
of canines and was named human bocavirus 1 (HBoV 1) 
[2]. Later, three additional types were characterized and 
named HBoV 2–4. To this date, HBoV is classified into 
Parvoviridae family and Bocaparvovirus genus, with two 
species that infect humans: Primate bocaparvovirus 1 that 
contains HBoV types 1 and 3, and Primate bocaparvovi-
rus 2 containing HBoV types 2 and 4 [3].
 Viral structure of HBoV is typical of Parvoviridae, 
that is, non-enveloped capsid of icosahedral symmetry 
and diameter of ~25nm. Viral genome is small linear 
single-stranded DNA, size only 5 kb in length with still 
unknown terminal sequences. Thereby, viral replication 
cycle is highly dependent on cellular functions, including 
DNA polymerase. The genome putatively encodes two 
forms of the nonstructural protein NS1 and, for bocavi-
ruses unique, nuclear phosphoprotein NP1, as well as two 
major structural proteins, VP1 and VP2 [4,5].
 HBoV 1 infects only well- differentiated or polarized 
primary human airway epithelial cells. After several at-
tempts, virus was finally successfully grown in cell culture 
[6,7], but the pathogenesis of HBoV still remains poorly 
characterized, mainly due to difficulties in replicating the 
virus in in vitro cell cultures and the lack of experimental 
animal models.
 Clinical significance of human bocaviruses has been 
studied over past decade, and it is generally accepted that 
HBoV 1 is associated with respiratory tract infections. 
Pneumonia, bronchiolitis, acute otitis media, the common 
cold, and exacerbations of asthma are the most common 
clinical manifestations of HBoV 1 respiratory tract in-
fections, with cough, fever, rhinitis, and wheezing being 
the most prominent symptoms [8-17]. Primary infection 
occurs early in life, similar as for other respiratory virus-
es, such as respiratory syncytial virus (RSV), rhinovi-
ruses and human metapneumovirus. By the age of 6 the 
HBoV 1-specific IgG seroprevalence is 80% [18,19], still, 
due to incomplete immunity or falling immune status in 
old age, symptomatic reinfections can occur. Other three 
types (HBoV 2-4) have been detected in stool samples 
but their association with gastrointestinal illness is con-
troversial [20,21]. HBoV 1-4 have been also identified in 
samples other than respiratory and gastrointestinal tract. 
Besides respiratory tract, HBoV 1 can be found in serum 
of symptomatic patients with ARI, pointing to a systemic 
spread [8], but also in asymptomatic healthy individuals. 
Namely, it has been detected in up to 5% of pooled hu-
man plasma thus making possible concern in transfusion 
medicine [22,23]. Additionally, it has been identified in 
cerebrospinal fluid of children with encephalitis in a few 
cases [24,25].
 Due to the difficulties in replicating the virus in cell 
cultures, the diagnosis of HBoV infection is exclusively 
based on molecular detection methods [4,10]. Most lab-
oratories currently use in-house PCR and real-time PCR 
assays targeting the NP-1, NS-1 or VP1/2 gene, but oth-
er nucleic acid-based detection methods for the diagnosis 
of HBoV have also been described. A few commercially 
available approved multiplexing assays for respiratory vi-
ruses that have included HBoV detection have been devel-
oped and placed to the market [26].
 The aim of this report is to present results of the con-
tinuing one-year HBoV PCR detection in nasopharyngeal 
samples of children with ARI, hospitalized in two Cro-




 The samples to be screened were obtained from 275 
children consecutively admitted to the Children’s Hospital 
Zagreb and General Hospital Karlovac in the period from 
May 2017 to April 2018. The samples for molecular diag-
nostics on respiratory viruses were collected in children 
presented with symptoms of ARI, in whom viral etiology 
was suspected (according to the clinical manifestation and 
biochemical parameters - i.e. normal or slightly elevated 
white blood cells and/or C- reactive protein). Nasopharyn-
geal and pharyngeal swabs were collected using flocked 
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cluding software analysis displaying the results in form of 
electropherogram and virtual gel [27].
Statistical analysis
 Comparison between groups was performed using the 
Chi-square test, and statistical software on which all cal-
culations were made was “R”. P < 0.05 was considered 
significant.
Results
 Among 275 tested children there were 167 boys and 
108 girls. Gender distribution of tested patients, patients 
positive for any respiratory virus and patients positive for 
HBoV is shown in Figure 1. Ninety-nine of the tested pa-
tients were younger than one year, 78 were one to three 
years, 35 were three to five years and 63 of them were 
older than five years (Figure 2). Temporary distribution of 
collected and tested samples with the indicated rate of sam-
ples positive on any respiratory virus is shown in Figure 3.
 Viral etiology was proven in 221 /275 (80.4%) patients. 
Most frequently detected virus was rhinovirus, which was 
detected in 105 (38.2%) samples (in 63 samples as single 
virus - monoinfection), following RSV A/B in 51 sample 
(18.5%) (monoinfection in 26 samples) and adenovirus in 49 
(17.8%) samples (monoinfection in 11 samples) (Figure 4).
 Human bocavirus was detected in 17 samples (6.2%) 
from 11 males and six females. (Figure 1.) Among them 
the youngest child was two months old and the oldest 
was 51 months, and average age of HBoV infected chil-
dren was 21 months. Most children with HBoV infection 
(70.2%) were between the ages of one and three years 
(Figure 5), as opposed to the children infected with other 
swab, combined and placed into viral transport medium 
(UTM™, Copan Italy). The swabs were transported at 
+4°C to the Laboratory within 48 hours were they were 
stored at −80°C until tested. Specimens were accompa-
nied with demographic data and clinical diagnosis.
 The study was approved by the Ethics Committee of 
the Teaching Institute of Public Health „Dr. Andrija Štam-
par”. Written consent was obtained from the children’s 
parents or caretakers.
Laboratory diagnosis
 Detection of HBoV was performed by real time RT-
PCR and it included three major steps: nucleic acid iso-
lation, target amplification and detection of product. To 
isolate viral DNA and RNA from viral transport medium, 
300 µL was extracted according to the manufacturer’s 
protocol using Ribospin™ vRD kit (Gene All Biotech-
nology, Seoul, Korea). Target amplification was done by 
using multiplex one-step RT-PCR assay, Seeplex® RV15 
OneStep ACE Detection (Seegene, Seoul, Korea) on ther-
mal cycler GeneAmp® 9700 PCR System (Applied Bio-
systems, Foster City, USA) which simultaneously ampli-
fies target sequences of 15 respiratory viruses: influenza A 
virus, influenza B virus, RSV type A, RSV type B, human 
adenovirus, human metapneumovirus, human coronavirus 
229E/NL63, human coronavirus OC43, human parain-
fluenza virus 1,2,3 and 4, human rhinovirus A/B/C, hu-
man enterovirus and human bocavirus 1/2/3/4. Seeplex® 
RV15 Onestep ACE Detection assay includes two internal 
controls: PCR control and whole process control to en-
sure that PCR worked properly. Products of amplification 
were detected by microchip electrophoresis detection on 
MCE®-202 MultiNA device (Shimadzu, Kyoto, Japan) in-
Figure 1. Distribution of tested patients by gender: a) all tested patients, b) all patients with sample positive for any respiratory virus, 
c) patients with sample positive for human bocavirus (HBoV)
Slika 1. Raspodjela ispitanika po spolu a) svi testirani pacijenti, b) pacijenti s uzorkom pozitivnim na respiratorne viruse, c) paci-
jenti s uzorkom pozitivnim na humani bokavirus (HBoV)
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6). There was no significant differences in localization of 
infection (URTI vs. LRTI) when comparing HBoV posi-
tive patients with other respiratory virus positive patients 
(P = 0.08). In five samples, only HBoV pathogen was de-
tected, thus coinfection with other respiratory viruses was 
found in 12 samples, including detection of rhinovirus, 
adenovirus, coronavirus, RSV type B and enterovirus 
(Figure 7 and Figure 8). HBoV is significantly more often 
respiratory viruses that were mostly up to 1 year old (P = 
0.002). HBoV was detected in older children when com-
pared to the children infected with respiratory syncytial 
virus (P < 0.001), but younger when compared to those 
infected with influenza (P = 0.009).
 Thirteen children with detected HBoV had infection 
of upper respiratory tract infection (URTI) and four chil-
dren had lower respiratory tract infection (LRTI) (Figure 
Figure 2. Age group distribution of all tested patients with acute respiratory infection (ARI) during May 1st, 2017- April 30th 2018 
(N=275)
Slika 2. Raspodjela svih ispitanika po dobi u razdoblju od 1. svibnja 2017. do 30. travnja 2018. (N=275)
Figure 3. Number of collected and tested samples (May 1st, 2017- April 30th 2018); N=275
Slika 3. Broj prikupljenih i testiranih uzoraka po mjesecima (od 1. svibnja 2017. do 30.travnja 2018.); N=275
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Figure 4. Frequency of detected viruses in samples with positive multiplex PCR for respiratory virus (HRV= human rhinovirus 
A/B/C, RSV A/B= respiratory syncitial virus A and B, AdV= adenovirus, HCov OC43=human coronavirus OC43, Flu A/
B=influenza A and B virus, HBoV= human bocavirus 1/2/3/4, HEV= human enterovirus, HMPV=human metapneumovirus, 
PIV 1= parainfluenza virus type 1, HCoV 229/NL63=human coronavirus 229E/NL63, PIV 3= parainfluenza virus type 3, 
PIV 4= parainfluenza virus type 4)
Slika 4. Učestalost detektiranih virusa u uzorcima s pozitivnim multipleks PCR testom na respiratorne viruse (HRV = humani rino-
virus A/B/C, RSV A/B = respiratorni sincicijski virus A i B, AdV = adenovirus, HCoV OC43 = humani koronavirus OC43, 
Flu A/B = virus influence A i B, HBoV = humani bokavirus 1/2/3/4, HEV = humani enterovirus, HMPV = humani metapneu-
movirus, PIV 1 = virus parainfluence tip 1, HCoV 229/NL63 = humani koronavirus 229E/NL63, PIV 3 = virus parainfluence 
tip 3, PIV 4 = virus parainfluence tip 4)
Figure 5. Age group distribution of children with detected human bocavirus (HBoV)
Slika 5. Raspodjela po dobi ispitanika s detektiranim humanim bokavirusom (HBoV)
detected together with other respiratory virus when com-
pare to the other respiratory viruses (P < 0.001).
 In one child with HBoV positive sample, bacterial in-
fection was confirmed and BHS-A from pharyngeal swab 
was detected. Four HBoV positive children received em-
piric antibiotic therapy. None of 17 HBoV positive chil-
dren needed mechanic ventilation or oxygen therapy. The 
average duration of hospitalization of HBoV positive pa-
tients was 5.7 days. HBoV is detected throughout the year, 
except for the summer months (Figure 9).
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Figure 6. Localization of acute respiratory infection in patients 
with detected human bocavirus (HBoV) (URTI= 
upper respiratory tract infection, LRTI= lower respi-
ratory tract infection)
Slika 6. Lokalizacija akutne respiratorne infekcije kod paci-
jenata s detektiranim humanim bokavirusom (HBoV) 
(IGDS= infekcija gornjeg dišnog sustava, IDDS= in-
fekcija donjeg dišnog sustava)
Figure 7. Monoinfection and coinfection rate of human bocavi-
rus (HBoV) and HBoV with other respiratory viruses, 
respectively
Slika 7. Učestalost monoinfekcije s humanim bokavirusom 
(HBoV) i koinfekcije HBoV s drugim virusima
Figure 8. Number of viruses detected in coinfections with human bocavirus (HBoV)
Slika 8. Broj detektiranih virusa u koinfekciji s humanim bokavirusom (HBoV)
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10.1 % of respiratory samples and average co-infection of 
38.7% [4].
 Although Koch’s postulates cannot be completely ful-
filled for HBoV, due to the lack of adequate animal and cell 
culture models, there is substantial evidence suggesting 
that HBoV1 is indeed an etiological pathogen of respiratory 
tract disease, rather than an innocent bystander, especially 
in children under five years of age [2]. Common respiratory 
clinical syndrome of upper and lower respiratory tract lo-
calization (i.e. otitis media acuta and bronchiolitis, respec-
tively) are strongly associated with HBoV detection in young 
children [17, 29]. Some studies found that HBoV is, after 
rhinoviruses, RSV A/B and adenoviruses, most commonly 
associated virus in community-acquired viral pneumonia 
in childhood [30-32]. Moreover, newer studies suggest that 
severe HBoV infection relates to an increased risk of some 
chronic diseases (i.e. HBoV bronchiolitis in infancy is also 
strongly associated with recurrent wheezing and exacerba-
tion of asthma) [33]. However, the unambiguous interpre-
tation of the HBoV detection complicates the large proportion 
of its co-detection with other viruses as well as its finding 
in asymptomatic persons. The long persistence and long 
shedding of HBoV 1 in the nasopharynx, up to 50 days, 
could explain the high rate of co-detection with common 
respiratory microorganisms, but still complicates the inter-
pretation of positive DNA amplification test results [34,35]. 
According to some authors, it seems that sole PCR positivity 
in the airways is not fully reliable diagnostic marker of pri-
mary human bocavirus infection. Detection of anti-HBoV 
1 antibodies or viral DNA in serum or of HBoV 1 spliced 
mRNA, high copies of viral DNA or antigen in airway samples 
is a more reliable tool to detect primary infection [36-38]. 
Discussion
 Since its discovery in 2005, many different studies 
have reported prevalence of HBoV in acute respiratory 
infections, ranging from 1.0% to 56.8%, depending on the 
country and population under investigation [2,3]. There 
are scarce data on HBoV prevalence in respiratory tract 
infection for Croatia. The first report of HBoV detection 
in Croatia revealed its frequency detection rate of 10.5% 
in respiratory samples of children with ARI but on small 
sample size (n=72) [27]. The most recent data from retro-
spective study that searched for HBoV in respiratory sam-
ples of 295 children with lower respiratory tract disease 
showed prevalence of 23.1% [28]. This report presents 
results from first year of 4-year prospective study reveal-
ing HBoV prevalence of 6.2% in respiratory samples of 
children with symptoms and signs of ARI of both, URTI 
and LRTI, which is lower than prevalence found in pre-
viously mentioned studies. However, all studies indicate 
that in a significant proportion of respiratory samples of 
Croatian children with ARI, HBoV was identified. The 
rate of co-infection/co-detection of HBoV with other res-
piratory viruses also varies in different studies worldwide, 
and ranges from 8.3% to 100%. [2,4]. In this study, HBoV 
was co-detected with other respiratory viruses in 70% of 
cases, which is highly consistent with continuous findings 
of high co-detection rate (87.5% and 51%) in other Croa-
tian studies [27,28]. It is also in line with studies from It-
aly who showed average prevalence of 7.4% and average 
co-detection rate of 62.8% [4]. The highest prevalence av-
erages in Europe have been reported for Hungary (29.8%) 
with co-detection with other respiratory viruses of 53.6 
%. [4]. Prevalence studies from Germany found HBoV in 
Figure 9. Temporal distribution of samples positive for human bocavirus (HBoV) in period of May 1st 2017- April 30th 2018 (N=17)
Slika 9. Raspodjela uzoraka pozitivnih na humani bokavirus (HBoV) tijekom perioda od 1. svibnja 2017. do 30. travnja 2018. (N=17)
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As HBoV 1 serological assays are not yet commercially 
available, and due to high viral loads correlate with acute 
infections, fewer coinfections and increased disease severity, 
some authors advocate use of quantitative PCR for diag-
nosis of HBoV acute infection and cut off value of >104 
HBoV 1 genomes/mL of nasopharyngeal secretion [10,39].
 In this study, 12 of 17 (70. 6%) children with detected 
HBoV were between one and three years of age; they were 
older than RSV infected children, but younger than influ-
enza infected children. This finding is also consistent with 
the results of previous Croatian study [28], who also showed 
that detection rates of HBoV infection increased with age, 
while RSV infection rates decreased with age. Few sero-
prevalence studies have revealed that protective maternal 
antibodies are present in infants younger than two months 
of age and after that seropositivity decreases with lowest 
prevalence in the 6- to 12-month age group [34,35], which 
may explain why most symptomatic infections occur be-
tween one and three years of age. HBoV 1 is detectable 
less frequently in other age groups including adults. The 
reason for that is probably because reinfection occurs 
throughout life and the high prevalence of antibodies re-
mains into adulthood. Although it is generally accepted 
that reinfections in adults are mostly mild or asymptomat-
ic, some studies conducted on tissue samples have discov-
ered HBoV as a single viral agent in 17% mucosal sam-
ples from adults with chronic sinusitis, leaving possibility 
that HboV also plays pathogenic role in adults [40].
 Similar as in other studies [39], HBoV was detected 
throughout whole year except summer months, predominant-
ly during cold periods of year and peak low temperatures in 
winter months. However, to find out more about seasonality 
of this virus in Croatia, because of small sample number 
and one-year period of research, further research is needed.
 In conclusion, although often detected in combination 
with other respiratory viruses, HBoV is one of the possible 
causes of ARI in children. Detection of HBoV in the res-
piratory secretion need to be included in standard respira-
tory viruses’ panel for routine laboratory diagnosis of 
ARI. Continuous HBoV detection is required in order to 
complete our findings on clinical significance and epide-
miology of this infection.
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